A new whitepaper from Esco documents the surrogate performance test results of the company's Pharmacon Downflow Booths.
These tests were carried out according to the good-practice guidelines on Assessing the Particulate Containment Performance of Pharmaceutical Equipment, published by the International Society for Pharmaceutical Engineering (ISPE).
A comprehensive series of tests, including filter integrity, downflow, bleed airflow, light intensity and noise level was carried out to verify the performance of the Esco Pharmacon Downflow Booth.
Booth performance was established to be both within industry accepted- and manufacturer's criteria.
A surrogate powder test involving the hand transfer of 25kg of lactose, in accordance with the ISPE Good Practice Guidelines, was then carried out.
Multiple air-sampling positions were strategically located at the operator breathing zone, both inside and outside the booth.
Laboratory analysis of the sampling discs recovered indicated that booth performance was excellent, with all sampling locations - including the critical operator breathing zone - reading significantly less than the industry-accepted criteria of 100ug/m3.
For more details, download the white paper from the company's website.
Downflow Booths provide containment by utilising high velocity air to capture airborne dust particles.
Downflow Booths are versatile devices that can control exposure risk to hazardous materials for a wide variety of equipment and processes.
They enhance cGMP practices.
